About
Technology
Therapeutics
Partnering
Careers
Newsroom
Contact
Twitter
Linkedin
info@bighatbio.com
About
About
Technology
Technology
Therapeutics
Therapeutics
Partnering
Partnering
Careers
Careers
Newsroom
Newsroom
Twitter
Twitter
Linkedin
Linkedin
Contact Us
The Latest
Newsroom
All
Announcements
Press
Publications
Presentations
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
4.24.2024
BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Press
12.5.2023
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Press
Recent Posts
7.20.2022
BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies
Announcements
6.23.2022
BigHat’s CSO and VP Engineering speaking at AWS Summit San Francisco
Announcements
5.11.2022
BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors
Announcements
3.28.2022
BigHat Biosciences Completes Its Acquisition of Frugi Biotechnology
Announcements
3.8.2022
Luminaries Rob Chess, Mark Pegram and Michael Jewett join BigHat’s Advisory Board
Announcements
3.1.2022
BigHat in Pharma’s Almanac Q1 2022 Issue
Announcements
2.23.2022
BigHat’s CEO and CSO on BIOS Builders podcast
Announcements
1.13.2022
BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference
Announcements
1.11.2022
BigHat Biosciences Completes First Stage of Research Collaboration with Amgen
Announcements
12.22.2021
BigHat Holiday Memo 2021
Announcements
10.30.2021
BigHat’s New Facility
Announcements
10.27.2021
BigHat Wins “2021 Therapeutics Innovation of the Year” from BioTech Breakthrough
Announcements
Previous
2 / 5
Next
© BigHat Bio 2023
.png)
